Pharmaceuticals & Healthcare Outlook For 2018: Central & Eastern Europe
Pharma & Healthcare / Europe / Tue 05 Dec, 2017
Drugmakers in Central and Eastern Europe will continue to benefit from the region's high pharmaceutical market growth potential although widespread public healthcare funding issues may restrict revenue growth. In 2018, a number of governments will seek to address these issues through the transformation of healthcare systems while pharmaceutical